Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Apr 8;16(5):363-367.
doi: 10.1016/j.jor.2019.03.014. eCollection 2019 Sep-Oct.

Assessment of glycosaminoglycan content in intervertebral discs of patients with leg length discrepancy: A pilot study

Affiliations

Assessment of glycosaminoglycan content in intervertebral discs of patients with leg length discrepancy: A pilot study

David Latz et al. J Orthop. .

Abstract

Objective: Leg length discrepancy (LLD) could be a predisposing factor for early degeneration of lumbar intervertebral discs (IVD). The purpose of this study was to elucidate the molecular effect of LLD on IVDs.

Methods: IVDs of Eleven patients (25.6 ± 4.3years) with LLD (>10 mm) and 14 control subjects (23.9 ± 3.5years) were compared using a 3T-MR scanner. Morphological T2-weighted and glycosaminoglycan-chemical-exchange-saturation-transfer (gagCEST) sequences were performed.

Results: No differences in morphological Pfirrmann grading were found (p > 0.05). In contrast, nucleus-pulposus-gagCEST-values of L5/S1 were significantly lower (p = 0.0008).

Conclusion: Our results suggest that LLD is a predisposing factor for molecular IVD alterations, which are detectable even before morphological pathologies could be found.

Keywords: Chemical exchange saturation transfer (CEST); Glycosaminoglycan (GAG); Intervertebral disc degeneration; Leg length discrepancy; Magnetic resonance imaging (MRI); Preventive medicine.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Comparison of NP-gagCEST values of L5/S1 IVD between patients with LLD >10 mm and control subjects.
Fig. 2
Fig. 2
Color-coded gagCEST map with high GAG content in blue and low GAG content in red of the lumbar spine (L1–S1). On the left side, a participant without leg length discrepancy (LLD) with high GAG content (blue IVDs), and on the right side, a patient with LLD demonstrating molecular alteration of the lumbar disc on level L5/S1 with low GAG content in red and orange. Pfirrmann grading illustrates no morphological disc degeneration with scores of 1 or 2.
Fig. 3
Fig. 3
Color-coded gagCEST map with high GAG content in blue and low GAG content in red of the lumbar spine (L1–S1). Another example of a participant without LLD on the left side compared to a patient with LDD on the right side. On level L5/S1, the patient with LLD (right side) showed significantly lower GAG content compared to control participant. All discs revealed no morphological disc degeneration with Pfirrmann score 1 or 2 (not shown in this picture).

References

    1. Morscher E. Hungerford DS, Hrsg. Leg Length Discrepancy the Injured Knee. Springer Berlin Heidelberg; Berlin, Heidelberg: 1977. Etiology and pathophysiology of leg length discrepancies; pp. 9–19.
    1. Gogia P.P., Braatz J.H. Validity and reliability of leg length measurements. J Orthop Sport Phys Ther. 1986;8:185–188. - PubMed
    1. Thomann K.-D., Schröter F., Grosser V. Elsevier Health Sciences; 2013. Orthopädisch-unfallchirurgische Begutachtung: Praxis der klinischen Begutachtung.
    1. Giles L., Taylor J. Low-back pain associated with leg length inequality. Spine. 1981;6:510–521. - PubMed
    1. Kendall J.C., Bird A.R., Azari M.F. Foot posture, leg length discrepancy and low back pain – their relationship and clinical management using foot orthoses – an overview. Foot. 2014;24:75–80. - PubMed

LinkOut - more resources